Cargando…
Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV
INTRODUCTION: Entry inhibitors are a relatively new class of antiretroviral therapy and are typically indicated in heavily treatment experienced individuals living with HIV. Despite this, there is no formal definition of ‘heavily treatment experienced’. Interpretation of this term generally includes...
Autores principales: | Orkin, Chloe, Cahn, Pedro, Castagna, Antonella, Emu, Brinda, Harrigan, P Richard, Kuritzkes, Daniel R., Nelson, Mark, Schapiro, Jonathan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546304/ https://www.ncbi.nlm.nih.gov/pubmed/35293094 http://dx.doi.org/10.1111/hiv.13288 |
Ejemplares similares
-
HIV-1 Entry, Inhibitors, and Resistance
por: Lobritz, Michael A., et al.
Publicado: (2010) -
Closing two doors of viral entry: Intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1
por: Kopetzki, Erhard, et al.
Publicado: (2008) -
HIV: how to manage heavily treatment-experienced patients
por: Spivack, Stephanie, et al.
Publicado: (2022) -
HIV-1 Entry and Membrane Fusion Inhibitors
por: Xiao, Tianshu, et al.
Publicado: (2021) -
HIV envelope: challenges and opportunities for development of entry inhibitors
por: Caffrey, Michael
Publicado: (2011)